CMS's D-SNP integration overhaul rewards insurers that already run state Medicaid managed-care plans — and Elevance has the contracts Cigna gave up.
The mechanism: CMS's Contract Year 2026 Medicare Advantage final rule forces dual-eligible special needs plans (D-SNPs) — coverage for the roughly 12 million Americans on both Medicare and Medicaid — toward real integration. By 2027, qualifying D-SNPs must issue a single combined Medicare-Medicaid ID card and run one integrated health risk assessment instead of duplicative ones. CMS also created an Integrated Care Special Enrollment Period letting full-benefit duals switch into an integrated D-SNP in any month specifically to align with their state's Medicaid managed-care organization (MCO). That last piece is the money mechanic: the easiest, most compliant integrated D-SNP to sell a dual-eligible member is one run by the same company that already holds their state Medicaid MCO contract. Distribution, not underwriting, is now the moat.
Who cashes in. ELV is the direct play — Elevance runs Medicaid MCOs in roughly 14-plus states and already serves D-SNP members across 22 states, giving it an existing case-management and provider-network rail to cross-sell integrated duals product without building state relationships from scratch. UNH, via UnitedHealthcare Community & State, is the scale leader with Medicaid contracts across the most states of any insurer and a D-SNP book to match — it captures the same integration tailwind at even larger volume. HUM benefits asymmetrically on the Medicare side: Humana is the single largest standalone MA/D-SNP writer and, even with a thinner Medicaid MCO footprint than Elevance or Centene, integration rules that push CMS to reward high-quality integrated plans in Star Ratings and bonus payments favor its scale in duals administration. CNC, despite recent Medicaid-margin turbulence, holds Medicaid contracts in more states than almost anyone and is explicitly rebuilding around integrated duals as a growth vector once its state-rate resets stabilize.
The easiest, most compliant integrated D-SNP to sell a dual-eligible member is one run by the same company that already holds their state's Medicaid contract — distribution, not underwriting, is now the moat.
Who is exposed. CI is structurally locked out of this entire trade: Cigna completed the $3.7 billion sale of its Medicare Advantage, Part D, and CareAllies businesses to Health Care Service Corporation in March 2025, fully exiting Medicare Advantage. With no MA or D-SNP platform left, Cigna cannot cross-sell into integrated duals at all — the exact gap this rule change punishes. CVS (Aetna) carries real D-SNP membership but a comparatively thin state Medicaid MCO base next to Elevance, Centene, or UnitedHealthcare, forcing it to compete for integrated-duals enrollment through payer relationships rather than incumbent state contracts — a structural disadvantage as the SEP makes switching easier.
The play: This is a distribution-advantage story, not a rate story — watch state Medicaid MCO re-procurements (Nevada, Illinois, and others cycling through 2026) as the leading indicator of who gets first crack at co-branded integrated D-SNP enrollment. What to watch: CMS D-SNP state-specific contract filings and Elevance's D-SNP membership disclosures in coming 10-Qs for cross-sell conversion evidence.
Source: original report ↗
Free alerts Free: catalyst alerts, straight to your inbox.
Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $40/mo Join the owners who run ahead of the industry. Cancel anytime, one click.
